Back to search

United Kingdom· GB-APID-14121711000001100

Gabapentin 600mg tablets

A gabapentin product containing gabapentin, registered in United Kingdom by Consilient Health Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC N02BF01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedGabapentin 600mg tabletsATCN02BF01REGISTER NO.GB-APID-1412171100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Gabapentin is registered in 16 of 19 countries.

Countries holding a registration under ATC N02BF01 (gabapentin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Gabapentin · ATC N02BF01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of gabapentin costs, country by country.

Normalised to the WHO defined daily dose (1.8 g), the median price runs from $0.19 in United States to $3.62 in Switzerland — a ×19 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Gabapentin · price per daily dose (1.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.62
  • IT Italy$2.46
  • US United States$0.19 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Gabapentin
Manufacturer
Consilient Health Ltd
Country
United Kingdom (GB)
ATC code
N02BF01
ATC class
Gabapentin
Defined daily dose
1.8 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5015525070716

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

298 interactions on record for gabapentin.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gabapentin · interactions on record

298 records

  • 4 severe
  • 47 moderate
  • 10 minor
  • 237 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gabapentin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gabapentin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Gabadal, Gabapentin !@ctavis
  • Belgium · Gabapentin Sandoz, Gabapentine Eg
  • Bulgaria · Габагамма, Gabagamma, Неуронтин
  • Cyprus · Gabantin, Gabapentin Accord
  • Czechia · Gabagamma, Gabanox
  • Germany · Gabagamma, Gabaliquid Geriasan
  • Denmark · Gabamed, Gabapenstad
  • Estonia · Gabagamma, Gabapentin Accord
  • Spain · Gabapentin Strides, Gabapentina Almus
  • Finland · Gabapentin Accord, Gabapentin Actavis
  • France · Gabapentin Teva, Gabapentine Arrow Generiques
  • Greece · Elpichoc, Gabantin
  • Croatia · Katena, Neurontin
  • Hungary · Gabagamma, Garonoan
  • Ireland · Gabapentin Accord, Gabapentin Accord Healthcare Ireland
  • Iceland · Gabagen, Gabapentin Pcd
  • Italy · Gabapentin Abc, Gabapentin Almus
  • Lithuania · Gabagamma, Gabapentin Accord
  • Luxembourg · Gabapentine Eg, Neurontin
  • Latvia · Gabagamma, Gabapentin Aurobindo
  • Malta · Gabapentin Ascend, Gabapentin Aurobindo
  • Netherlands · Gabapentin Aurobindo, Gabapentine Accord
  • Norway · Gabapentin Strides, Gabapentin Teva
  • Poland · Epigapent, Gabapentin Aurovitas
  • Portugal · Gabamox, Gabapentin Ratiopharm
  • Romania · Gabagamma, Gabalept
  • Sweden · Gabapentin 1a Farma, Gabapentin Accord
  • Slovenia · Neurontin
  • Slovakia · Gabagamma, Gabapentin Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d2419776-3366-4929-a78c-c276458fabb8
GET /v1/drugs/d2419776-3366-4929-a78c-c276458fabb8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "14121711000001100",
  "desc": "Gabapentin 600mg tablets (Consilient Health Ltd)",
  "form": "Oral tablet",
  "vpid": "42129911000001106",
  "source": "dmd",
  "vtm_id": "776060008",
  "strength": "600 mg",
  "substance": "Gabapentin",
  "ingredient": "Gabapentin",
  "supplier_code": "10309611000001109"
}

See everything about gabapentin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.